Health Catalyst, Inc. (HCAT) Research
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Market snapshot
- Symbol
- HCAT
- Price
- $1.74
- Day change
- -1.69%
- Market cap
- $128.6M
- P/E ratio
- -0.48x
- 52-week range
- 0.955-4.125
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Next earnings
- in 2 months
- Analyst price target
- $2.25
Peer companies
Recent insider activity
- Albert Benjamin — F-InKind (34485 shares) on 2026-06-10
- Albert Benjamin — F-InKind (336 shares) on 2026-06-01
- Llewelyn Linda — F-InKind (8519 shares) on 2026-06-01
- Alger Jason — F-InKind (18804 shares) on 2026-06-01
- Landry Benjamin — F-InKind (13779 shares) on 2026-06-01
Open Health Catalyst, Inc. (HCAT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.